Industry experts say Frank Torti could be the successor to FDA commissioner Andrew von Eschenbach, who is expected to leave the post following the November election. Torti outlined a plan for his first 100 days as FDA's chief scientist at an FDA Science Board appearance, giving insight into his policy plans at the agency. A partial transcript is available here.

Full Story:

Related Summaries